Making vaccines more effective

September 19, 2012 by Catherine Somerville
Dr Irina Caminschi.

(Medical Xpress)—Scientists have discovered an important mechanism in which a synthetic DNA targets the immune system that could significantly improve the effectiveness of future vaccines.

This was published today in the (PNAS) journal.

Burnet Institute Centre for Immunology Laboratory Head, Dr Irina Caminschi, has identified for the first time a new receptor (DEC-205) that binds to the (known as CpG),

"CpG is very immune-stimulatory, it makes the immune system more reactive, which is why it is used in vaccines. It is currently in clinical trials for cancer and malaria vaccines," Dr Caminschi said.

"While testing it for various immune responses, we discovered a mechanism that elicits that very strong reaction."

Though researchers have used CpG to enhance immune responses, it was unknown which receptor the used to actually grab the DNA and internalise it for recognition.

"Essentially by understanding how the immune system recognises this foreign, synthetic DNA and the rules that govern this recognition, we can exploit it so that when it gets used in a vaccine it works better," Dr Caminschi said.

Explore further: Newest cancer therapies multi-task to eliminate tumors

Related Stories

Scientists discover new 'off switch' in immune response

February 28, 2012

Scientists from Trinity College Dublin have discovered a new 'off switch' in our immune response which could be boosted in diseases caused by over-activation of our immune system, or blocked to improve vaccines. The findings ...

Manipulating the immune system to develop 'next-gen' vaccines

April 5, 2012

The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by 'tricking' cells into launching an immune response, leading to next-generation vaccines that are more specific, ...

Recommended for you

Team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can "paralyze" CD4 T cells, immune components that help ...

SIV shrugs off antibodies in vaccinated monkeys

August 11, 2015

New research on monkeys vaccinated against HIV's relative SIV calls into question an idea that has driven AIDS vaccine work for years. The assumption: a protective vaccine only needs to stimulate moderate levels of antibodies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.